Loading ETF profile…
The fund aims to achieve its investment goals by primarily building a portfolio of U.S.-listed securities from companies based outside the United States, frequently using American Depositary Receipts (ADRs). At least 80% of the fund's total assets will be invested in ADRs and other securities that exhibit similar economic characteristics.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| BBVA | BANCO BILBAO VIZCAYA-SP ADR | 4.86% | $2.00M |
| MUFG | MITSUBISHI UFJ FINL-SPON ADR | 4.58% | $1.88M |
| CYD | CHINA YUCHAI INTL LTD | 4.42% | $1.81M |
| BCS | BARCLAYS PLC-SPONS ADR | 4.15% | $1.71M |
| — | NOKIA CORP-SPON ADR | 3.92% | $1.61M |
| TSM | TAIWAN SEMICONDUCTOR-SP ADR | 3.78% | $1.55M |
| BVN | CIA DE MINAS BUENAVENTUR-ADR | 3.33% | $1.37M |
| ASND | ASCENDIS PHARMA A/S | 3.20% | $1.31M |
| SMFG | SUMITOMO MITSUI-SPONS ADR | 3.16% | $1.30M |
| GFIOF | GOLD FIELDS LTD-SPONS ADR | 3.16% | $1.30M |
| CX | CEMEX SAB-SPONS ADR PART CER | 2.91% | $1.20M |
| RYCEY | ROLLS-ROYCE HOLDINGS-SP ADR | 2.82% | $1.16M |
| NVS | NOVARTIS AG-SPONSORED ADR | 2.75% | $1.13M |
| EONGY | E.ON SE -SPONSORED ADR | 2.73% | $1.12M |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 2.67% | $1.10M |
| ESLT | ELBIT SYSTEMS LTD | 2.63% | $1.08M |
| GSK | GSK PLC-SPON ADR | 2.57% | $1.06M |
| SGAPY | SINGAPORE TELECOMMUNICAT-ADR | 2.53% | $1.04M |
| VIV | TELEFONICA BRASIL-ADR | 2.50% | $1.03M |
| BTI | BRITISH AMERICAN TOB-SP ADR | 2.45% | $1.00M |
| ERIC | ERICSSON (LM) TEL-SP ADR | 2.40% | $986.73K |
| UGP | ULTRAPAR PARTICPAC-SPON ADR | 2.32% | $953.99K |
| ABVX | ABIVAX SA-ADR | 2.28% | $939.00K |
| CMPS | COMPASS PATHWAYS PLC | 2.26% | $929.82K |
| AER | AERCAP HOLDINGS NV | 2.25% | $925.08K |